FMP

FMP

Enter

RGC - Regencell Bioscience...

photo-url-https://images.financialmodelingprep.com/symbol/RGC.png

Regencell Bioscience Holdings Limited

RGC

NASDAQ

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

5.17 USD

0.03 (0.58%)

RGC Financial Statements

Year

2024

2023

2022

2021

Total Revenue

0

0

0

0

Cost of Revenue

745.59k

769.69k

604.4k

26.46k

Gross Profit

-745.59k

-769.69k

-604.4k

-26.46k

Operating Expenses

3.99M

6.27M

7.62M

1.38M

Research and Development

1.07M

1.58M

2.51M

438.32k

Selling, General & Administrative Expenses

2.92M

4.69M

5.11M

943.04k

Selling & Marketing Expenses

0

262.66k

25.27k

1.58k

General & Administrative Expenses

0

4.43M

5.08M

941.46k

Other Expenses

0

211.34k

23.21k

34.62k

Operating Income

-4.74M

-6.27M

-7.62M

-1.38M

Total Other Income/Expenses Net

373.5k

211.34k

23.21k

34.62k

Income Before Tax

-4.36M

-6.06M

-7.59M

-1.35M

Income Tax

312.13k

-191.2k

-171.83k

-210.1k

Net Income

-4.3M

-5.87M

-7.42M

-1.35M

Basic EPS

-0.33

-0.45

-0.57

-0.11

EPS Diluted

-0.33

-0.45

-0.57

-0.11

Basic Average Shares

13.01M

13.01M

13.01M

12.64M

Diluted Average Shares

13.01M

13.01M

13.01M

12.64M

EBITDA

-3.62M

-5.29M

-6.99M

-1.35M

Retained Earning Schedule

Year

2024

2023

2022

2021

Retained Earnings (Previous Year)

-17.32M

-11.44M

-4M

-2.65M

Net Income

-4.3M

-5.87M

-7.42M

-1.35M

Stock Repurchases

0

0

0

0

Dividend Paid

0

0

0

0

Retained Earnings

-21.62M

-17.32M

-11.44M

-4M

Other Distributions

-4.3M

-5.87M

-7.45M

-1.35M

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

226.51k

891.91k

1.46M

81.86k

Annual Depreciation

745.59k

769.69k

604.4k

26.46k

Capital Expenditure

-5.38k

-27.39k

-780.88k

0

Net PPE

-513.7k

149.62k

1.64M

55.41k

Intangible and Goodwill Schedule

Year

2024

2023

2022

2021

Acquisitions and Adjustments

0

0

0

0

Goodwill (Previous Year)

0

0

0

0

Goodwill

0

0

0

0

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep